Cargando…
Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T (1)H-MRS Study
BACKGROUND: Glutathione (GSH), a major intracellular antioxidant, plays a role in NMDA receptor-mediated neurotransmission, which is involved in the pathophysiology of schizophrenia. In the present study, we aimed to investigate whether GSH levels are altered in the posterior medial frontal cortex o...
Autores principales: | Matsuzawa, Daisuke, Obata, Takayuki, Shirayama, Yukihiko, Nonaka, Hiroi, Kanazawa, Yoko, Yoshitome, Eiji, Takanashi, Junichi, Matsuda, Tsuyoshi, Shimizu, Eiji, Ikehira, Hiroo, Iyo, Masaomi, Hashimoto, Kenji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275307/ https://www.ncbi.nlm.nih.gov/pubmed/18398470 http://dx.doi.org/10.1371/journal.pone.0001944 |
Ejemplares similares
-
Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects
por: Fukami, Goro, et al.
Publicado: (2010) -
Changes in Self-Regulation-Related Prefrontal Activities in Eating Disorders: A Near Infrared Spectroscopy Study
por: Sutoh, Chihiro, et al.
Publicado: (2013) -
Glutathione and glutamate in schizophrenia: a 7T MRS study
por: Kumar, Jyothika, et al.
Publicado: (2018) -
Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients
por: Hashimoto, Kenji, et al.
Publicado: (2005) -
Relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection: A national survey in Japan
por: Shiina, Akihiro, et al.
Publicado: (2020)